Intrauterine exposure to mild analgesics is a risk factor for development of male reproductive disorders in human and rat

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Intrauterine exposure to mild analgesics is a risk factor for development of male reproductive disorders in human and rat. / Kristensen, David Møbjerg; Hass, Ulla; Lesné, Laurianne; Lottrup, Grete; Jacobsen, Pernille Rosenskjold; Desdoits-Lethimonier, Christele; Boberg, Julie; Petersen, Jørgen Holm; Toppari, Jorma; Jensen, Tina Kold; Brunak, Søren; Skakkebaek, Niels E; Nellemann, Christine; Main, Katharina M; Jégou, Bernard; Leffers, Henrik.

In: Human Reproduction, Vol. 26, No. 1, 2011, p. 235-44.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Kristensen, DM, Hass, U, Lesné, L, Lottrup, G, Jacobsen, PR, Desdoits-Lethimonier, C, Boberg, J, Petersen, JH, Toppari, J, Jensen, TK, Brunak, S, Skakkebaek, NE, Nellemann, C, Main, KM, Jégou, B & Leffers, H 2011, 'Intrauterine exposure to mild analgesics is a risk factor for development of male reproductive disorders in human and rat', Human Reproduction, vol. 26, no. 1, pp. 235-44. https://doi.org/10.1093/humrep/deq323

APA

Kristensen, D. M., Hass, U., Lesné, L., Lottrup, G., Jacobsen, P. R., Desdoits-Lethimonier, C., Boberg, J., Petersen, J. H., Toppari, J., Jensen, T. K., Brunak, S., Skakkebaek, N. E., Nellemann, C., Main, K. M., Jégou, B., & Leffers, H. (2011). Intrauterine exposure to mild analgesics is a risk factor for development of male reproductive disorders in human and rat. Human Reproduction, 26(1), 235-44. https://doi.org/10.1093/humrep/deq323

Vancouver

Kristensen DM, Hass U, Lesné L, Lottrup G, Jacobsen PR, Desdoits-Lethimonier C et al. Intrauterine exposure to mild analgesics is a risk factor for development of male reproductive disorders in human and rat. Human Reproduction. 2011;26(1):235-44. https://doi.org/10.1093/humrep/deq323

Author

Kristensen, David Møbjerg ; Hass, Ulla ; Lesné, Laurianne ; Lottrup, Grete ; Jacobsen, Pernille Rosenskjold ; Desdoits-Lethimonier, Christele ; Boberg, Julie ; Petersen, Jørgen Holm ; Toppari, Jorma ; Jensen, Tina Kold ; Brunak, Søren ; Skakkebaek, Niels E ; Nellemann, Christine ; Main, Katharina M ; Jégou, Bernard ; Leffers, Henrik. / Intrauterine exposure to mild analgesics is a risk factor for development of male reproductive disorders in human and rat. In: Human Reproduction. 2011 ; Vol. 26, No. 1. pp. 235-44.

Bibtex

@article{4a030018075f4eaa92456085f61ae6c1,
title = "Intrauterine exposure to mild analgesics is a risk factor for development of male reproductive disorders in human and rat",
abstract = "BACKGROUND More than half of pregnant women in the Western world report intake of mild analgesics, and some of these drugs have been associated with anti-androgenic effects in animal experiments. Intrauterine exposure to anti-androgens is suspected to contribute to the recent increase in male reproductive problems, and many of the anti-androgenic compounds are like the mild analgesics potent inhibitors of prostaglandin synthesis. Therefore, it appears imperative to further investigate the potential endocrine disrupting properties of mild analgesics. METHODS In a prospective birth cohort study, 2297 Danish and Finnish pregnant women completed a questionnaire and 491 of the Danish mothers participated in a telephone interview, reporting on their use of mild analgesics during pregnancy. The testicular position of newborns was assessed by trained paediatricians. In rats, the impact of mild analgesics on anogenital distance (AGD) after intrauterine exposure was examined together with the effect on ex vivo gestational day 14.5 testes. RESULTS In the Danish birth cohort, the use of mild analgesics was dose-dependently associated with congenital cryptorchidism. In particular, use during the second trimester increased the risk. This risk was further increased after the simultaneous use of different analgesics. The association was not found in the Finnish birth cohort. Intrauterine exposure of rats to paracetamol led to a reduction in the AGD and mild analgesics accordingly reduced testosterone production in ex vivo fetal rat testes. CONCLUSION There was an association between the timing and the duration of mild analgesic use during pregnancy and the risk of cryptorchidism. These findings were supported by anti-androgenic effects in rat models leading to impaired masculinization. Our results suggest that intrauterine exposure to mild analgesics is a risk factor for development of male reproductive disorders.",
keywords = "Acetaminophen, Analgesics, Animals, Aspirin, Cohort Studies, Cryptorchidism, Female, Humans, Ibuprofen, Infertility, Male, Male, Pregnancy, Prenatal Exposure Delayed Effects, Rats, Risk Factors",
author = "Kristensen, {David M{\o}bjerg} and Ulla Hass and Laurianne Lesn{\'e} and Grete Lottrup and Jacobsen, {Pernille Rosenskjold} and Christele Desdoits-Lethimonier and Julie Boberg and Petersen, {J{\o}rgen Holm} and Jorma Toppari and Jensen, {Tina Kold} and S{\o}ren Brunak and Skakkebaek, {Niels E} and Christine Nellemann and Main, {Katharina M} and Bernard J{\'e}gou and Henrik Leffers",
year = "2011",
doi = "10.1093/humrep/deq323",
language = "English",
volume = "26",
pages = "235--44",
journal = "Human Reproduction",
issn = "0268-1161",
publisher = "Oxford Academic",
number = "1",

}

RIS

TY - JOUR

T1 - Intrauterine exposure to mild analgesics is a risk factor for development of male reproductive disorders in human and rat

AU - Kristensen, David Møbjerg

AU - Hass, Ulla

AU - Lesné, Laurianne

AU - Lottrup, Grete

AU - Jacobsen, Pernille Rosenskjold

AU - Desdoits-Lethimonier, Christele

AU - Boberg, Julie

AU - Petersen, Jørgen Holm

AU - Toppari, Jorma

AU - Jensen, Tina Kold

AU - Brunak, Søren

AU - Skakkebaek, Niels E

AU - Nellemann, Christine

AU - Main, Katharina M

AU - Jégou, Bernard

AU - Leffers, Henrik

PY - 2011

Y1 - 2011

N2 - BACKGROUND More than half of pregnant women in the Western world report intake of mild analgesics, and some of these drugs have been associated with anti-androgenic effects in animal experiments. Intrauterine exposure to anti-androgens is suspected to contribute to the recent increase in male reproductive problems, and many of the anti-androgenic compounds are like the mild analgesics potent inhibitors of prostaglandin synthesis. Therefore, it appears imperative to further investigate the potential endocrine disrupting properties of mild analgesics. METHODS In a prospective birth cohort study, 2297 Danish and Finnish pregnant women completed a questionnaire and 491 of the Danish mothers participated in a telephone interview, reporting on their use of mild analgesics during pregnancy. The testicular position of newborns was assessed by trained paediatricians. In rats, the impact of mild analgesics on anogenital distance (AGD) after intrauterine exposure was examined together with the effect on ex vivo gestational day 14.5 testes. RESULTS In the Danish birth cohort, the use of mild analgesics was dose-dependently associated with congenital cryptorchidism. In particular, use during the second trimester increased the risk. This risk was further increased after the simultaneous use of different analgesics. The association was not found in the Finnish birth cohort. Intrauterine exposure of rats to paracetamol led to a reduction in the AGD and mild analgesics accordingly reduced testosterone production in ex vivo fetal rat testes. CONCLUSION There was an association between the timing and the duration of mild analgesic use during pregnancy and the risk of cryptorchidism. These findings were supported by anti-androgenic effects in rat models leading to impaired masculinization. Our results suggest that intrauterine exposure to mild analgesics is a risk factor for development of male reproductive disorders.

AB - BACKGROUND More than half of pregnant women in the Western world report intake of mild analgesics, and some of these drugs have been associated with anti-androgenic effects in animal experiments. Intrauterine exposure to anti-androgens is suspected to contribute to the recent increase in male reproductive problems, and many of the anti-androgenic compounds are like the mild analgesics potent inhibitors of prostaglandin synthesis. Therefore, it appears imperative to further investigate the potential endocrine disrupting properties of mild analgesics. METHODS In a prospective birth cohort study, 2297 Danish and Finnish pregnant women completed a questionnaire and 491 of the Danish mothers participated in a telephone interview, reporting on their use of mild analgesics during pregnancy. The testicular position of newborns was assessed by trained paediatricians. In rats, the impact of mild analgesics on anogenital distance (AGD) after intrauterine exposure was examined together with the effect on ex vivo gestational day 14.5 testes. RESULTS In the Danish birth cohort, the use of mild analgesics was dose-dependently associated with congenital cryptorchidism. In particular, use during the second trimester increased the risk. This risk was further increased after the simultaneous use of different analgesics. The association was not found in the Finnish birth cohort. Intrauterine exposure of rats to paracetamol led to a reduction in the AGD and mild analgesics accordingly reduced testosterone production in ex vivo fetal rat testes. CONCLUSION There was an association between the timing and the duration of mild analgesic use during pregnancy and the risk of cryptorchidism. These findings were supported by anti-androgenic effects in rat models leading to impaired masculinization. Our results suggest that intrauterine exposure to mild analgesics is a risk factor for development of male reproductive disorders.

KW - Acetaminophen

KW - Analgesics

KW - Animals

KW - Aspirin

KW - Cohort Studies

KW - Cryptorchidism

KW - Female

KW - Humans

KW - Ibuprofen

KW - Infertility, Male

KW - Male

KW - Pregnancy

KW - Prenatal Exposure Delayed Effects

KW - Rats

KW - Risk Factors

U2 - 10.1093/humrep/deq323

DO - 10.1093/humrep/deq323

M3 - Journal article

C2 - 21059752

VL - 26

SP - 235

EP - 244

JO - Human Reproduction

JF - Human Reproduction

SN - 0268-1161

IS - 1

ER -

ID: 34138445